Anti-Racism in Public Health Act of 2025
Sponsor
Full profile: /officials/W000817
Source: Congress.gov · FEC
Cosponsors (4)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Committee Activity
Currently in
- Senate Committee on Health, Education, Labor, and PensionsReferred To · 2025-04-11
Previously
- Health, Education, Labor, and Pensions CommitteeReferred To · 2025-04-11
Plain-English Summary
This bill would require the federal government to develop and implement strategies to address racial disparities in public health outcomes, such as differences in disease rates, maternal mortality, and access to healthcare among different racial groups. It would direct health agencies to collect better data on health inequities, train healthcare workers on recognizing and reducing racial bias, and establish programs aimed at improving health services in underserved communities. The legislation would affect public health agencies, hospitals, healthcare providers, and communities experiencing worse health outcomes due to systemic inequalities.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- S4648A bill to improve transparency with respect to foreign influence on Department of Defense contractors.Referred to Committee · 2026-06-01
- S4550Maternal Health Pandemic Response ActReferred to Committee · 2026-05-18
- SRES732A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.Referred to Committee · 2026-05-14
- S4509PBM ActReferred to Committee · 2026-05-13